Cas9 News and Research

RSS
New gene-editing treatment extends lifespan in mice with prion disease

New gene-editing treatment extends lifespan in mice with prion disease

Functional characterization of variants improves cancer risk assessment and treatment

Functional characterization of variants improves cancer risk assessment and treatment

SPLICER shows promise in Alzheimer's and other diseases

SPLICER shows promise in Alzheimer's and other diseases

Study unveils NAD's link to aging and disease development

Study unveils NAD's link to aging and disease development

New approach in fighting leukemia with double-modified natural killer cells

New approach in fighting leukemia with double-modified natural killer cells

Nutrient metabolism regulates T cell exhaustion and therapy potential

Nutrient metabolism regulates T cell exhaustion and therapy potential

Researchers use innovative approach to uncover hidden bioactive compounds in bacteria

Researchers use innovative approach to uncover hidden bioactive compounds in bacteria

Study uncovers dangerous side effects of AZD7648 in gene editing

Study uncovers dangerous side effects of AZD7648 in gene editing

Aging of lung stem cells drives iron deficiency and reduces capacity for tumor formation

Aging of lung stem cells drives iron deficiency and reduces capacity for tumor formation

Ultrasound-controlled CRISPR offers precision in treating genetic disorders

Ultrasound-controlled CRISPR offers precision in treating genetic disorders

Fas-p53 pathway drives metabolic dysfunction and obesity-linked insulin resistance

Fas-p53 pathway drives metabolic dysfunction and obesity-linked insulin resistance

Targeting intracellular checkpoints to enhance NK cell immunotherapy

Targeting intracellular checkpoints to enhance NK cell immunotherapy

First U.S. trial uses non-viral CRISPR to correct sickle cell mutation

First U.S. trial uses non-viral CRISPR to correct sickle cell mutation

ESGCT Conference Takeaways:  A specialty laboratory perspective

ESGCT Conference Takeaways: A specialty laboratory perspective

Small brain-penetrating molecule offers hope for treating aggressive brain tumors

Small brain-penetrating molecule offers hope for treating aggressive brain tumors

CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis

CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis

MaxCyte celebrates 25 years of innovation driving cell engineering-based therapeutics

MaxCyte celebrates 25 years of innovation driving cell engineering-based therapeutics

Key reason why some cancers do not respond to immunotherapy identified

Key reason why some cancers do not respond to immunotherapy identified

CRISPR technology reveals essential noncoding RNAs in the human genome

CRISPR technology reveals essential noncoding RNAs in the human genome

New targets identified for treating glioblastoma through genetic screen

New targets identified for treating glioblastoma through genetic screen

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.